Abiopharma

New Form 8-K - Sintx Technologies, Inc. Filed: 2025-06-27 AccNo: 0001641172-25-016891 Size: 618 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits